Alerts will be sent to your verified email
Verify EmailADLINE
|
Adline Chem Lab
|
Ganga Pharma.
|
Kobo Biotech
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
65.02 % | 0.71 % | 11.35 % |
|
5yr average Equity Multiplier
|
0.93 | 1.37 | 4.06 |
|
5yr Average Asset Turnover Ratio
|
0.25 | 0.31 | 0.54 |
|
5yr Avg Net Profit Margin
|
15.43 % | 1.72 % | -3.79 % |
|
Price to Book
|
0.0 | 0.98 | 0.0 |
|
P/E
|
0.0 | 89.76 | 0.0 |
|
5yr Avg Cash Conversion Cycle
|
0.0 | 237.0 Days | 0.0 |
|
Inventory Days
|
40.82 Days | 165.67 Days | 89.28 Days |
|
Days Receivable
|
0.0 | 126.89 Days | 0.0 |
|
Days Payable
|
61.52 Days | 119.78 Days | 147.48 Days |
|
5yr Average Interest Coverage Ratio
|
10.45 | 1.32 | 0.99 |
|
5yr Avg ROCE
|
-27.86 % | 3.77 % | 11.79 % |
|
5yr Avg Operating Profit Margin
|
-8.78 % | 0.19 % | 8.83 % |
|
5 yr average Debt to Equity
|
-0.21 | 0.28 | 1.62 |
|
5yr CAGR Net Profit
|
-37.71 % | 31.95 % | n/a |
|
5yr Average Return on Assets
|
-1534.04 % | 0.53 % | -0.89 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
25.85 % | 50.91 % | 44.95 % |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
-2.39 % | -15.8 % | 0.0 |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | 0.0 |
|
Adline Chem Lab
|
Ganga Pharma.
|
Kobo Biotech
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|